Publisher Correction: Radioactive drugs emerge from the shadows to storm the market
- PMID: 30659240
- DOI: 10.1038/s41587-019-0030-5
Publisher Correction: Radioactive drugs emerge from the shadows to storm the market
Abstract
In the version of this article initially published, Betalutin was described as directing a radioisotope to CD45-expressing B cells; in fact, it directs it to CD37-expressing B cells. The error has been corrected in the HTML and PDF versions of the article.
Erratum for
-
Radioactive drugs emerge from the shadows to storm the market.Nat Biotechnol. 2018 Dec 6;36(12):1125-1127. doi: 10.1038/nbt1218-1125. Nat Biotechnol. 2018. PMID: 30520873 No abstract available.
Publication types
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous